Clinical Assessment of DAILIES TOTAL1® (DT1) Multifocal
NCT ID: NCT02871375
Last Updated: 2018-07-02
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
170 participants
INTERVENTIONAL
2016-08-30
2016-11-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Evaluation of DAILIES TOTAL 1® Multifocal Compared to 1-Day Acuvue® Moist® Multifocal in a Japanese Population
NCT03341923
Initial Performance of a Daily Disposable Contact Lens Featuring Molded Marks
NCT02939170
Initial Performance of a Modified Daily Disposable Contact Lens
NCT02694835
Clinical Evaluation of the Safety and Efficacy of a New Multifocal Contact Lens
NCT01797783
Performance Evaluation of DAILIES® TOTAL1™ in First Time Contact Lens Wearers
NCT01494545
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DT1 MF, then Habitual
Delefilcon A multifocal contact lenses in Period 1, followed by subject's habitual multifocal contact lenses in Period 2. Each product worn bilaterally (in both eyes) for 14 ± 3 days.
Delefilcon A multifocal contact lenses
Multifocal contact lenses worn in a daily wear, daily disposable modality (new pair of lenses each morning)
Habitual multifocal contact lenses
Multifocal contact lenses worn per subject's habitual prescription and habitual daily wear modality
Habitual, then DT1 MF
Subject's habitual multifocal contact lenses in Period 1, followed by delefilcon A multifocal contact lenses in Period 2. Each product worn bilaterally (in both eyes) for 14 ± 3 days.
Delefilcon A multifocal contact lenses
Multifocal contact lenses worn in a daily wear, daily disposable modality (new pair of lenses each morning)
Habitual multifocal contact lenses
Multifocal contact lenses worn per subject's habitual prescription and habitual daily wear modality
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Delefilcon A multifocal contact lenses
Multifocal contact lenses worn in a daily wear, daily disposable modality (new pair of lenses each morning)
Habitual multifocal contact lenses
Multifocal contact lenses worn per subject's habitual prescription and habitual daily wear modality
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Current daily wearer of soft multifocal contact lenses for at least 6 months with symptoms of contact lens discomfort as defined by the prescreening Eligibility Questionnaire;
* Requires a near spectacle add of +0.50 to +2.50 diopters (D) (inclusive);
* Requires lenses within the power range of study lenses to be fitted;
* Best corrected VA (BCVA) of 20/30 (0.2 logarithmic minimum angle of resolution \[logMAR\]) or better in each eye at distance;
* Willing to wear study lenses for a minimum of 5 days per week, 6 hours per day, and attend all study visits;
Exclusion Criteria
* Any use of medications for which contact lens wear could be contraindicated, as determined by the Investigator;
* Monocular (only one eye functional) or fit with only 1 lens;
* Fitted with monovision;
* Prior refractive surgery (e.g., laser vision correction, photorefractive keratectomy, etc.);
* History of herpetic keratitis, ocular surgery, or irregular cornea;
* Currently wearing DT1 MF contact lenses;
40 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon, a Novartis Company
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Project Manager, PLS
Role: STUDY_DIRECTOR
Alcon, A Novartis Division
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLE914-P001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.